Engineered Culture Models for Studies of Tumor-microenvironment Interactions
Overview
Affiliations
Heterogeneous microenvironmental conditions play critical roles in cancer pathogenesis and therapy resistance and arise from changes in tissue dimensionality, cell-extracellular matrix (ECM) interactions, soluble factor signaling, oxygen as well as metabolic gradients, and exogeneous biomechanical cues. Traditional cell culture approaches are restricted in their ability to mimic this complexity with physiological relevance, offering only partial explanation as to why novel therapeutic compounds are frequently efficacious in vitro but disappoint in preclinical and clinical studies. In an effort to overcome these limitations, physical sciences-based strategies have been employed to model specific aspects of the cancer microenvironment. Although these strategies offer promise to reveal the contributions of microenvironmental parameters on tumor initiation, progression, and therapy resistance, they, too, frequently suffer from limitations. This review highlights physicochemical and biological key features of the tumor microenvironment, critically discusses advantages and limitations of current engineering strategies, and provides a perspective on future opportunities for engineered tumor models.
Direct current electrical fields inhibit cancer cell motility in microchannel confinements.
Naggay B, Farahani S, Gao X, Holle A, Kemkemer R Sci Rep. 2025; 15(1):4605.
PMID: 39920207 PMC: 11806051. DOI: 10.1038/s41598-025-87737-7.
Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing.
Perucca A, Llonin A, Benach O, Hallopeau C, Rivas E, Linares J Nat Commun. 2025; 16(1):1279.
PMID: 39900918 PMC: 11790944. DOI: 10.1038/s41467-025-56275-1.
Application of three-dimensional (3D) bioprinting in anti-cancer therapy.
Wu B, Wu Z, Hou Y, Fang Z, Deng Y, Wu H Heliyon. 2023; 9(10):e20475.
PMID: 37800075 PMC: 10550518. DOI: 10.1016/j.heliyon.2023.e20475.
Apiz Saab J, Muir A Curr Opin Biotechnol. 2023; 83:102970.
PMID: 37494818 PMC: 10528471. DOI: 10.1016/j.copbio.2023.102970.
Advances in Brain Metastasis Models.
Lee J, Yang S Brain Tumor Res Treat. 2023; 11(1):16-21.
PMID: 36762804 PMC: 9911715. DOI: 10.14791/btrt.2022.0037.